Paxlovid begins blocking viral replication within hours of your first dose, but noticeable symptom improvement typically takes several days. In clinical trials, people who took Paxlovid recovered about 3 days faster than those who didn’t, with median recovery times ranging from 6 to 14 days depending on the study population.
What Happens Inside Your Body
Paxlovid works by disabling a specific enzyme the virus needs to make copies of itself. When the virus hijacks your cells, it produces long chains of protein that must be cut into smaller pieces before they can assemble into new viral particles. Paxlovid’s active ingredient locks onto the enzyme responsible for that cutting, essentially jamming the machinery. Without functional copies of itself, the virus can’t spread to new cells.
The second ingredient in the pill slows your liver from breaking down the first one, keeping drug levels high enough in your bloodstream to sustain this blockade. This is why Paxlovid interacts with so many other medications, but it’s also why the drug stays effective between doses.
This mechanism means Paxlovid doesn’t kill virus that’s already been produced. It stops the production line. Your immune system still has to clear the existing infection, which is why you won’t feel better immediately.
When You’ll Start Feeling Better
Two large trials give slightly different pictures of recovery speed, reflecting differences in the populations studied. In the CanTreatCOVID trial, people taking Paxlovid reached median recovery at 6 days, compared with 9 days for those receiving usual care. The larger PANORAMIC trial found median recovery at 14 days for the Paxlovid group versus 21 days without it. In both cases, Paxlovid shaved roughly 3 to 7 days off recovery.
Most people notice their worst symptoms (fever, body aches, fatigue) start easing within the first 2 to 3 days of treatment, though “recovery” in clinical trials means the point where symptoms are fully or nearly resolved. The drug’s effect on viral load becomes measurable by day 5, when treated patients show significantly greater reductions in the amount of virus in their nasal passages compared to untreated patients.
Early treatment matters. The standard course is twice a day for 5 days, and it needs to be started within 5 days of your first symptoms. The closer to symptom onset you begin, the more virus replication you prevent before it peaks. Waiting too long means the virus has already done most of its damage to your respiratory cells, and an antiviral has less to offer.
Why Starting Early Makes a Bigger Difference
COVID follows a predictable arc. Viral replication peaks in the first few days of illness, then the immune system’s inflammatory response takes over as the primary driver of symptoms. Paxlovid targets the replication phase. If you start it on day 1 or 2, you’re catching the virus near its peak production and cutting it short. By day 4 or 5, much of the replication has already occurred, and inflammation is doing most of the work of making you feel terrible.
This is why the 5-day treatment window exists. It’s not an arbitrary cutoff. It reflects the biology of when antivirals can meaningfully change the course of infection. If you test positive, the most important thing you can do is get a prescription quickly rather than waiting to see if you feel worse.
Who Can Take It
Paxlovid is approved for adults and for adolescents over 12 who weigh at least 88 pounds (40 kg). You need to have mild to moderate COVID, meaning you’re not sick enough to be hospitalized, and you need at least one risk factor for developing severe illness. Your prescriber makes that determination based on your medical history, considering factors like age, chronic conditions, and immune status.
The Rebound Question
Some people feel better after finishing the 5-day course, then experience a return of symptoms a few days later. This “rebound” has gotten a lot of attention, but the rates are lower than many people assume. A large observational study found rebound occurred in about 6.6% of Paxlovid-treated patients, which was not statistically different from the 4.5% rebound rate in people who received no treatment at all. Some smaller studies have reported higher rates, in the 10% to 14% range.
When rebound does happen, it typically shows up 3 to 7 days after symptoms first resolve. The median time to viral rebound is about 9 days after initial diagnosis, and it generally resolves on its own by around day 16. Rebound illness tends to be mild. It does not mean the treatment failed or that you need a second course.
Medications That May Complicate Timing
Because one of Paxlovid’s ingredients affects how your liver processes drugs, a long list of common medications can’t be taken alongside it. This includes several blood thinners (like rivaroxaban and dabigatran), cholesterol-lowering statins (like atorvastatin, simvastatin, and lovastatin), certain heart rhythm medications, the gout drug colchicine, and immunosuppressants used after organ transplants.
Some of these need to be paused before you even start Paxlovid. Certain immunosuppressants, for example, should be stopped 24 to 48 hours beforehand. Others need to stay paused for several days after your last Paxlovid dose, for a total of up to 8 days from your first pill. If you take any prescription medications regularly, your prescriber will need to review them before writing the prescription. This is worth sorting out in advance so drug interactions don’t delay your start date during the critical early window.